Related Experiment Video
Updated: May 22, 2026
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 28, 2007
Pharmaceutical strategy and innovation: an academics perspective
Ian R Baxendale1, John J Hayward, Steven V Ley
1Innovative Technology Centre, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
Chemmedchem
|April 27, 2007
Summary
The pharmaceutical industry faces financial pressures from investors and generic competition, leading to strategic shifts like outsourcing. Innovation and productivity challenges persist, impacting drug development timelines and corporate strategies.
Area of Science:
- Pharmaceutical industry
- Chemical sciences
- Global market analysis
Background:
- Increasing financial pressures from investors and generic drug manufacturers.
- Growing demand for cheaper, safer drugs from consumers and health authorities.
- Concerns regarding the pharmaceutical industry's scientific productivity and innovation levels.
Purpose of the Study:
- To discuss the financial and strategic challenges facing the global pharmaceutical market.
- To investigate the root causes of these industry-wide issues.
- To highlight key hurdles, particularly those related to chemical sciences.
Main Methods:
- Literature review and analysis of industry trends.
- Examination of corporate strategies and outsourcing practices.
- Assessment of innovation and productivity metrics within the pharmaceutical sector.
Main Results:
- Pharmaceutical companies are increasingly using outsourcing to manage financial pressures.
- Productivity and innovation in drug development are under scrutiny.
- Uncertainties exist regarding current corporate strategies and their effectiveness.
Conclusions:
- The pharmaceutical industry must address significant financial and operational challenges.
- Overcoming hurdles in chemical sciences is crucial for future innovation and market success.
- Strategic adaptation is necessary to navigate the evolving global pharmaceutical landscape.
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).